[1]袁强华,宋英,方芳,等.心舒通颗粒提取工艺研究[J].中国中医药信息杂志,2013,20(3):62-65.[doi:10.3969/j.issn.1005-5304.2013.03.024]
 YUAN Qiang-hua,SONG Ying,FANG Fang,et al.Study on Extraction Process for Xinshutong Particles[J].zhongguo zhongyiyao xinxi zazhi,2013,20(3):62-65.[doi:10.3969/j.issn.1005-5304.2013.03.024]
点击复制

心舒通颗粒提取工艺研究

参考文献/References:

[1] 靳维荣,孙强,单成钢,等.丹参药材中丹参酮ⅡA含量测定方法改进[J].时珍国医国药,2010,21(7):1672-1673.

[2] 徐淑卿,孙艳秋,陈桂范.用正交试验法优选丹参脂溶性成分的提取工艺[J].中成药,1999,21(3):152-153.

[3] 强凤霞.正交设计法研究丹参酮最佳提取工艺[J].中国医学研究与临床,2003,11(1):17-19.

[4] 张岱州,裴志东,李春雪,等.HPLC法测定消疲宁颗粒中丹参素钠含量[J].辽宁中医药大学学报,2010,7(12):179-180.

[5] 王志朝,匡长春,李强.双丹胶囊的制备与质量标准研究[J].医药导报, 2007,11(26):1344-1345.

[6] 芦志伟,李美珍,卢欣等.HPLC法测定参花通脉胶囊中丹参素钠的含量[J].天津医科大学学报,2012,2(18):260-262.

[7] 徐强,章曙丹,冯瑛.HPLC测定糖肾颗粒中葛根素的含量[J].中成药, 2007,29(4):622.

[8] 国家药典委员会.中华人民共和国药典:一部[S].北京:中国医药科技出版社,2010:附录ⅩA.

[9] 徐德然,王康才,王峥涛,等.丹参中丹参素、原儿茶醛来源的初步研究[J].中国天然药物,2005,3(3):148-150.

[10] 刘海波,徐峻,彭勇,等.丹参活血化瘀活性成分的靶标[J].物理化学学报,2010,26(1):199-205.

相似文献/References:

[1]李浩,刘开祥,俸军林.丹参酮ⅡA对脑缺血再灌注损伤大鼠脑组织及血清中NO含量及NOS、iNOS活性的影响[J].中国中医药信息杂志,2009,16(1):40.
 LI Hao,LIU Kai-xiang,FENG Jun-lin.Effect of Tanshinone ⅡA on Content of NO and Activities of NOS and iNOS in Cerebral Ischemic Reperfusion Injury Rats[J].zhongguo zhongyiyao xinxi zazhi,2009,16(3):40.
[2]李彬,任海华.正交设计优选解酒肝康颗粒的提取工艺[J].中国中医药信息杂志,2008,15(6):54.
 LI Bin,REN Hai-hua.Optimization of Extracting Technology of Jiejiu Gankang Granules by Orthogonal Design[J].zhongguo zhongyiyao xinxi zazhi,2008,15(3):54.
[3]张明,刘汉清,韩晓珂,等.SFE-CO2和超声法提取丹参药渣的对比研究[J].中国中医药信息杂志,2008,15(12):59.
 ZHANG Ming,LIU Han-qing,HAN Xiao-ke,et al.Comparative Study of SFE-CO2 and Ultrasonic in Extracting the Water Decocted Radix Salviae Miltiorrhiza[J].zhongguo zhongyiyao xinxi zazhi,2008,15(3):59.
[4]张明辉,张培彤,周天.丹参酮ⅡA对乏氧环境下人高转移性巨细胞肺癌细胞表面β1-整合素及E-cadherin表达的影响[J].中国中医药信息杂志,2012,19(1):39.[doi:10.3969/j.issn.1005-5304.2012.01.014]
 ZHANG Ming-hui,ZHANG Pei-tong,ZHOU Tian.Effect of Tanshinon ⅡA on Expression of β1-integrin and E-cadherin on the Surface of Cell PG Cultured in Hypoxic Environment[J].zhongguo zhongyiyao xinxi zazhi,2012,19(3):39.[doi:10.3969/j.issn.1005-5304.2012.01.014]
[5]顾媛媛,田军军.HPLC测定参归胶囊中丹参酮ⅡA的含量[J].中国中医药信息杂志,2012,19(1):58.[doi:10.3969/j.issn.1005-5304.2012.01.021]
 GU Yuan-yuan,TIAN Jun-jun.Content Dertermination of Tanshinone ⅡA in Shengui Capsule by HPLC[J].zhongguo zhongyiyao xinxi zazhi,2012,19(3):58.[doi:10.3969/j.issn.1005-5304.2012.01.021]
[6]谭银合,孙维广,谭弘.丹龙抗痴胶囊提取工艺研究[J].中国中医药信息杂志,2008,15(5):56.
 TAN Yin-he,SUN Wei-guang,TAN Hong.Study on Extraction Process of Danlong Kangchi Capsules[J].zhongguo zhongyiyao xinxi zazhi,2008,15(3):56.
[7]刘效栓,焦正花,李喜香,等.RP-HPLC测定制萎扶胃丸中隐丹参酮和丹参酮ⅡA含量[J].中国中医药信息杂志,2013,20(8):54.[doi:10.3969/j.issn.1005-5304.2013.08.019]
 [J].zhongguo zhongyiyao xinxi zazhi,2013,20(3):54.[doi:10.3969/j.issn.1005-5304.2013.08.019]
[8]刘效栓,李喜香,焦正花,等.附炎栓质量标准研究[J].中国中医药信息杂志,2010,17(12):48.[doi:10.3969/j.issn.1005-5304.2010.12.020]
 LIU Xiao-shuan,LI Xi-xiang,JIAO Zheng-hua,et al.Study on Quality Standard of Fuyanshuan[J].zhongguo zhongyiyao xinxi zazhi,2010,17(3):48.[doi:10.3969/j.issn.1005-5304.2010.12.020]
[9]李万红.宁心胶囊薄层色谱鉴别[J].中国中医药信息杂志,2010,17(8):40.[doi:10.3969/j.issn.1005-5304.2010.08.018]
 LI Wan-hong.TLC Identification of Ninxin Capsules[J].zhongguo zhongyiyao xinxi zazhi,2010,17(3):40.[doi:10.3969/j.issn.1005-5304.2010.08.018]
[10]任志会,苏会霞,柏艳柳.丹参脂溶性及水溶性成分集成提取工艺研究[J].中国中医药信息杂志,2009,16(3):54.
 REN Zhi-hui,SU Hui-xia,BAI Yan-liu.Study on the Integration Technique for Extracting Liposoluble and Water-soluble Components of Salvia Miltiorrniza[J].zhongguo zhongyiyao xinxi zazhi,2009,16(3):54.

备注/Memo

基金项目:国家中医药管理局重点课题(2011-H-HZ-04)

更新日期/Last Update: